PSS40 - COST-EFFECTIVENESS OF OCRIPLASMIN FOR THE TREATMENT OF VITREOMACULAR TRACTION, INCLUDING WHEN ASSOCIATED WITH MACULAR HOLE: A BELGIAN PERSPECTIVE

Autor:	C. Bennison, B. Lescrauwaet, R. Schmidt
Rok vydání:	2018
Předmět:	Cost effectiveness business.industry Health Policy Perspective (graphical) Ocriplasmin Public Health Environmental and Occupational Health Vitreomacular traction medicine.disease chemistry.chemical_compound chemistry medicine Optometry business Macular hole
Zdroj:	Value in Health. 21:S429
ISSN:	1098-3015
DOI:	10.1016/j.jval.2018.09.2540
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::76981ae7f8c8fe6083052491a8c8f70d https://doi.org/10.1016/j.jval.2018.09.2540 Zobrazit plný text záznamu Full Text from ScienceDirect